Inventor · disambiguated record
Allan Green
Also filed as: GREEN ALLAN · GREEN ALLAN L · GREEN ALLAN M
10 granted patents·15 pending applications·358 citations·filing 1974–2009
92Inventor score
Files withNEUROCHEM INT LTD3THESEUS IMAGING CORP3UNIV KINGSTON3GREEN ALLAN M2UNIV LELAND STANFORD JUNIOR2
Top patents by PatentIndex Score
25 records- 0192US6670399B2Compounds and methods for modulating cerebral amyloid angiopathyNEUROCHEM INT LTD·Filed 2000·Granted Dec 30, 2003·55 cites·17 claims
- 0289US6310073B1Methods and compositions to treat glycosaminoglycan-associated molecular interactionsUNIV KINGSTON·Filed 1999·Granted Oct 30, 2001·68 cites·5 claims
- 0383US5814647AUse of troglitazone and related compounds for the treatment of the climacteric symptomsUNIV TEXAS·Filed 1997·Granted Sep 29, 1998·51 cites·24 claims
- 0482US6843980B2Methods for using annexin for detecting cell death in vivo and treating associated conditionsTHESEUS IMAGING CORP·Filed 2002·Granted Jan 18, 2005·21 cites·20 claims
- 0582US6726895B2Method of imaging cell death in vivoUNIV LELAND STANFORD JUNIOR·Filed 2002·Granted Apr 27, 2004·16 cites·17 claims
- 0677US6200564B1Pharmaceutical compositions containing chondroitinase and uses thereforFiled 1998·Granted Mar 13, 2001·78 cites·6 claims
- 0776US4010251AScanning agent composition and use in imaging liver and for biliary functionGREEN ALLAN M·Filed 1974·Granted Mar 1, 1977·31 cites·15 claims
- 0875US6207690B1Troglitazone compounds for treating climacteric and cancerREGENTS THE UNIVERSITY TEXAS S·Filed 1999·Granted Mar 27, 2001·33 cites·26 claims
- 0969US2007078082A1Methods and compositions to treat glycosaminoglycan-associated molecular interactionsUNIV KINGSTON·Filed 2006·Application pending·0 cites
- 1063US2004096453A1Methods and compositions to treat glycosaminoglycan-associated molecular interactionsNEUROCHEM INT LTD·Filed 2003·Application pending·0 cites
- 1158US2009252704A1Therapies for cognition and learning enhancementGREEN ALLAN M·Filed 2009·Application pending·0 cites
- 1258US2006116347A1Methods and compositions to treat glycosaminoglycan-associated molecular interactionsKISILEVSKY ROBERT·Filed 2005·Application pending·0 cites
- 1358US2002193395A1Methods and compositions to treat glycosaminoglycan-associated molecular interactionsUNIV KINGSTON·Filed 2001·Application pending·0 cites
- 1457US8367071B2Verotoxin B subunit for immunizationINSERM TRANSFERT·Filed 2003·Granted Feb 5, 2013·0 cites·21 claims
- 1550US2008317834A1Compounds and methods for modulating cerebral amyloid angiopathyNEUROCHEM INT LTD·Filed 2003·Application pending·0 cites
- 1650US2004071739A1Methods of preparing an anti-tumor vaccineSELECT THERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 1748US2004170603A1Method of imaging cell death in vivoUNIV LELAND STANFORD JUNIOR·Filed 2004·Application pending·0 cites
- 1846US2003202939A1Methods for using annexin for detecting cell death in vivo and treating associated conditionsTHESEUS IMAGING CORP·Filed 2003·Application pending·0 cites
- 1946US2003103897A1Methods of using labelled verotoxin B subunitFiled 2002·Application pending·0 cites
- 2045US6579893B1Use of troglitazone and related compounds for the treatment of cancerUNIV TEXAS·Filed 1998·Granted Jun 17, 2003·5 cites·25 claims
- 2145US2009016956A1Labeled Macrophages and Methods of Use ThereofBENDER ROBERT·Filed 2008·Application pending·0 cites
- 2245US2005013778A1Methods and compositions for predicting the response to a therapeutic regimen in a subject having a disease associated with cell deathTHESEUS IMAGING CORP·Filed 2004·Application pending·0 cites
- 2342US2005177085A1Diabetic toe separatorsFiled 2004·Application pending·0 cites
- 2442US2005177084A1Diabetic toe protectorsFiled 2004·Application pending·0 cites
- 2529US2002081307A1Verotoxin b subunit for immunizationFiled 1999·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Allan Green files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →